Fundraising Fox

NanoVibronix

Elmsford, US · Delaware corporation

Biotech

Founders & leadership

BM
Brian MurphyChief Executive Officer and Director
JC
James CardwellChief Financial Officer
HJ
Harold JacobChief Medical Officer and Director
SB
Stephen BrownFormer Chief Financial Officer

Board

TM
Thomas MikaBoard director
MG
Martin GoldsteinBoard director
CF
Christopher FashekChairman of the Board of Directors
MF
Michael FergusonBoard director

Funding

SEC filings, press & company announcements

$32.3M disclosed across 14 of 17 rounds · 2003–2025

  • Undisclosed amountregistered direct offeringSep 2025
    Source ↗
▶$13.5MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen BrownExecutive Officer
  • Michael FergusonDirector
  • Maria SchroederDirector
  • Christopher FashekDirector
  • Harold JacobDirector
  • Martin GoldsteinDirector
  • Brian MurphyExecutive Officer, Director
  • Thomas R. MikaDirector
  • Aurora CassirerDirector
Offering amount
$13.5M
Amount sold
$13.5M
Sales commissions
$375K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJun 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen BrownExecutive Officer
  • Brian MurphyExecutive Officer, Director
  • Aurora CassirerDirector
  • Christopher FashekDirector
  • Mika R. ThomasDirector
  • Harold JacobExecutive Officer, Director
  • Maria SchroederDirector
  • Martin GoldsteinDirector
  • Michael FergusonDirector
Offering amount
$250K
Amount sold
$250K
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian MurphyExecutive Officer, Director
  • Stephen BrownExecutive Officer
  • Harold JacobExecutive Officer, Director
  • Christopher FashekDirector
  • Martin GoldsteinDirector
  • Michael FergusonDirector
  • Thomas MikaDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.6MraisedDec 2020 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen BrownExecutive Officer
  • Michael FergusonDirector
  • Harold JacobExecutive Officer, Director
  • Brian MurphyExecutive Officer, Director
  • Martin GoldsteinDirector
  • Christopher FashekDirector
  • Thomas MikaDirector
Offering amount
$6.6M
Amount sold
$6.6M
Sales commissions
$595K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedAug 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian MurphyExecutive Officer, Director
  • Thomas MikaDirector
  • James CardwellExecutive Officer
  • Martin GoldsteinDirector
  • Harold JacobExecutive Officer, Director
  • Christopher FashekDirector
  • Stephen BrownExecutive Officer
  • Michael FergusonDirector
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James CardwellExecutive Officer
  • Harold JacobExecutive Officer, Director
  • Michael FergusonDirector
  • Stephen BrownExecutive Officer
  • Brian MurphyExecutive Officer, Director
  • Martin GoldsteinDirector
  • Thomas MikaDirector
  • Christopher FashekDirector
Offering amount
$450K
Amount sold
$450K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FergusonDirector
  • Christopher FashekDirector
  • William SternExecutive Officer, Director
  • Thomas MikaDirector
  • Jona ZumerisExecutive Officer, Director
  • Stephen BrownExecutive Officer
  • Martin GoldsteinDirector
  • Brian MurphyExecutive Officer, Director
  • Harold JacobExecutive Officer, Director
Offering amount
$500K
Amount sold
$100K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedApr 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin GoldsteinDirector
  • Harold JacobExecutive Officer, Director
  • Stephen BrownExecutive Officer
  • Brian MurphyExecutive Officer, Director
  • Thomas MikaDirector
  • William SternExecutive Officer, Director
  • Jona ZumerisExecutive Officer, Director
  • Christopher FashekDirector
  • Michael FergusonDirector
Offering amount
$250K
Amount sold
$250K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

NanoVibronix raises $2 million in registered direct offering By Investing.cominvesting.com · Sep 2025$2M Capital Raise: Medical Tech Company NanoVibronix Secures Funding Through Direct Share Offeringstocktitan.net · Sep 2025Is NanoVibronix Inc (NAOV) Stock a Good Investment? | AAIIaaii.com · Dec 2022NanoVibronix raises 'bought deal' offering to $1.8M (NASDAQ:NAOV) | Seeking Alphaseekingalpha.com · Sep 2020NanoVibronix raises bought deal offering to $3.25M - News Breaknewsbreak.com · Aug 2020

Frequently asked questions

How much funding has NanoVibronix raised?
NanoVibronix has disclosed $32.3M raised across 14 of its 17 known rounds.
Where is NanoVibronix headquartered?
NanoVibronix is headquartered in Elmsford, US.